Dr. Ziaurrehman Tanoli – Drug repurposing – Best Researcher Award

Posted on by sciencefather

Dr. Ziaurrehman Tanoli – Drug repurposing – Best Researcher Award

University of Helsinki, Finland

Author Profiles

Google Scholar

Orcid

🎓Educational Background 

Dr. Tanoli completed his MS leading to PhD in Machine Learning at PIEAS and holds a Bachelor’s in Computer and Information Sciences from the same institution. In 2022, he was awarded the title of Docent in Pharmaceutical Chemistry by the University of Helsinki.

🏢Work Experience 

Dr. Tanoli has an extensive academic background, with experience in several prestigious institutions. Currently, he holds a position as a Senior Researcher at FIMM, and has previously served as an Associate Professor at the University of Helsinki. His prior roles include postdoctoral positions at FIMM, University of Helsinki, and the University of Sannio, Italy. He has also served as an Assistant Professor at COMSATS University Islamabad in Pakistan.

🏆Achievements 

Dr. Ziaurrehman Tanoli has established himself as an exceptional scientist, completing his PhD at the age of 27. His research has been widely recognized, with one of his most significant accomplishments being the publication of an article as the first author in Nature Reviews Drug Discovery (Impact Factor: 122). He co-organized the IDG-DREAM challenge, which was featured in Nature Communications in 2021. Dr. Tanoli also made notable strides in research challenges, such as winning the CTD2Pancancer Drug Activity Dream Challenge (CRM, 2022) and the CTD2Pancancer Chemosensitivity Dream Challenge (publication pending). His grant funding achievements include securing the AoF Project Funding (2022–2026) for €0.58M to support his project on drug repurposing and receiving a Young Researchers Grant (2023) from the Aaltonen Foundation for €37K. Furthermore, he has been awarded the MSCA SE EU Mobility Grant for €29K for the years 2025-2028.

🔬Research Expertise 

Dr. Tanoli specializes in AI-driven drug discovery, focusing on a variety of areas such as attention-based models, large language models, and generative AI for software development. His expertise extends to target-based drug discovery and repurposing, where he developed methods for predicting drug-target interactions across 7 protein superfamilies. He has also made significant contributions to phenotypic drug discovery, including multi-omics-based drug response prediction and synergistic drug combination identification. Dr. Tanoli has published 27 articles in the last five years, with 13 of them as corresponding or first author. His work has also expanded into the development of drug repurposing pipelines and drug safety analysis models.

💡Research Grants & Projects 

Throughout his career, Dr. Tanoli has secured numerous research grants and project funding for innovative drug discovery solutions. His projects span topics such as drug repurposing, AI models for drug discovery, and multi-omics analysis. The AoF Project (2022-2026) received €0.58M, and his other prestigious projects include the REMEDI4ALL EU Project (2022-2027) and EOSC-Life EU Project (2019-2023).

👩‍🏫Teaching & Supervision 

With over 300 contact hours of teaching, Dr. Tanoli has actively contributed to educational development. He has taught various topics related to pharmaceutical chemistry, machine learning, and bioinformatics. His dedication to mentorship is also evident through his supervision of 3 PhD students, 4 research assistants, 2 software developers, and 1 postdoc.

Notable Publications📝

📝Computational drug repurposing: approaches, evaluation of in silico resources and case studies

    • Authors: Ziaurrehman Tanoli, Adrià Fernández-Torras, Umut Onur Özcan, Aleksandr Kushnir, Kristen Michelle Nader, Yojana Gadiya, Laura Fiorenza, Aleksandr Ianevski, Markus Vähä-Koskela, Mitro Miihkinen et al.

    • Journal: Nature Reviews Drug Discovery

    • Year: 2025

📝Validation guidelines for drug-target prediction methods

    • Authors: Ziaurrehman Tanoli, Aron Schulman, Tero Aittokallio

    • Journal: Expert Opinion on Drug Discovery

    • Year: 2025

📝Machine Learning and Artificial Intelligence in Drug Repurposing—Challenges and Perspectives

    • Authors: Ezequiel Anokian, Judith Bernett, Adrian Freeman, Markus List, Lucía Prieto Santamaría, Ziaurrehman Tanoli, Sarah Bonnin

    • Journal: Drug Repurposing

    • Year: 2024

📝PGxDB: An interactive web-platform for pharmacogenomics research

    • Authors: Trinh Trung Duong Nguyen, Ziaurrehman Tanoli, Saad Hassan, Umut Özcan, Jimmy Caroli, Albert Kooistra, David Gloriam, Alexander Hauser

    • Journal: Nucleic Acids Research

    • Year: 2024

📝Attention-based approach to predict drug–target interactions across seven target superfamilies

    • Authors: Aron Schulman, Juho Rousu, Tero Aittokallio, Ziaurrehman Tanoli, Xin Gao

    • Journal: Bioinformatics

    • Year: 2024

 

Prof. Mahmoud Abd-Elkareem – Medicinal Chemistry – Best Researcher Award

Posted on by sciencefather

Prof. Mahmoud Abd-Elkareem – Medicinal Chemistry – Best Researcher Award

Assiut University, Egypt

Author Profile

Google Scholar

Scopus

Orcid

🎓Academic and Professional Background 

Mahmoud Abd-Elkareem Mahmoud is a Professor in the Department of Cell and Tissues at the Faculty of Veterinary Medicine, Assiut University. He has established himself as a distinguished researcher in the field of reproductive biology and histopathology. Over the years, he has published numerous high-impact articles in international journals, contributing significantly to the scientific community. In addition to his research, he serves as an editor and reviewer for various renowned international journals, ensuring the dissemination of high-quality scientific knowledge.

🔬Research Interests 

His research expertise spans multiple areas within biomedical sciences. His primary interests include reproductive biology, particularly focusing on the development of the ovary and embryology. He has also extensively studied stem cells, applying advanced techniques such as electron microscopy, histopathology, and immunohistochemistry. His work further extends into cytopathology and frozen section analysis, offering insights into cellular structures and disease pathology.

📑Ongoing Research & Projects 

Currently, Mahmoud Abd-Elkareem is leading an innovative research project on the effects of Miswak aqueous extract on reproductive performance. His study explores the therapeutic potential of Salvadora persica (Miswak), particularly in adult rats exposed to excess testosterone, with a special focus on its protective effects on the brain and testis. His research aims to uncover natural remedies for reproductive and neurological health challenges, advancing the field of alternative medicine and toxicology.

🏅Professional Memberships 

Mahmoud Abd-Elkareem actively participates in several professional organizations, contributing to quality assurance and scientific advancements in veterinary medicine. He is a member of the Quality Assurance and Accreditation Project and the Quality Assurance Unit at the Faculty of Veterinary Medicine, Assiut University. Additionally, he is affiliated with the Egyptian Society of Histology & Cytology, further strengthening his engagement with the global scientific community.

🌍Impact and Contributions 

With his extensive knowledge and commitment to scientific research, Mahmoud Abd-Elkareem continues to make remarkable contributions to the fields of histopathology, reproductive biology, and cytopathology. His dedication to academic excellence and innovative research has positioned him as a leading figure in veterinary and biomedical sciences.

Notable Publications📝

📝Antioxidant and cytoprotective effects of Nigella sativa L. seeds on the testis of monosodium glutamate challenged rats
  • Authors: Abd-Elkareem, M.; Abd El-Rahman, M.A.M.; Khalil, N.S.A.; Amer, A.S.

  • Journal: Scientific Reports

  • Year: 2021
📝Broiler welfare is preserved by long-term low-dose oral exposure to zinc oxide nanoparticles: preliminary study
  • Authors: Mahmoud, M.A.M.; Yahia, D.; Abdel-Magiud, D.S.; Darwish, M.H.A.; Abd-Elkareem, M.; Mahmoud, U.T.

  • Journal: Nanotoxicology

  • Year: 2021
📝Prebiotics reduce feather pecking behavior, and improve trace element profile and redox balance in Mule ducks
  • Authors: Mahmoud, U.T.; Mahmoud, M.A.M.; Abd-Elkareem, M.; Ahmed, F.A.M.; Khalil, N.S.A.

  • Journal: Journal of Veterinary Behavior

  • Year: 2021
📝Cytoprotective effect of Nigella sativa seed on 4-nonylphenol-induced renal damage in the African catfish (Clarias gariepinus)
  • Authors: Abd-Elkareem, M.; Abou Khalil, N.S.; Sayed, A.E.-D.H.

  • Journal: Chemosphere

  • Year: 2020
📝High-Payload chitosan microparticles for the colonic delivery of quercetin: Development and in-vivo evaluation in a rabbit colitis model
  • Authors: Helmy, A.M.; Elsabahy, M.; Abd-Elkareem, M.; Ibrahim, E.A.; Soliman, G.M.

  • Journal: Journal of Drug Delivery Science and Technology

  • Year: 2020

 

Mrs. Fatemeh Jahanmard – Pharmaceutical Chemistry – Best Researcher Award

Posted on by sciencefather

Mrs. Fatemeh Jahanmard – Pharmaceutical Chemistry – Best Researcher Award

Gilbert – Netherlands

Author Profile

Scopus

Google Scholar

🎓 Academic Background & Expertise

Mrs. Fatemeh Jahanmard Hosseinabadi holds a Ph.D. in Nanotechnology, specializing in formulation development, materials characterization, and drug delivery systems. With extensive expertise in these areas, she has contributed significantly to the advancement of polymeric and lipid-based nano/microparticles, antibacterial coatings, and hydrogel formulations for controlled drug release.

🔬 Postdoctoral Research & Scientific Contributions

She pursued four years of postdoctoral research at Utrecht University, where she developed advanced hydrogel coatings and nanoparticle-based drug delivery systems. Her work focused on innovative materials for biomedical applications, leading to the development of cutting-edge drug delivery platforms. During this time, she also mentored over ten graduate students, led multiple research projects, and managed laboratory operations, showcasing her leadership in academia.

🏥 Industry Leadership & Innovation

Currently serving as an R&D Manager at EHDA and Formulation Scientist at Gilbert, she plays a crucial role in bridging academia and industry. Her expertise in medical devices, biomaterials, coatings, and formulation science has been instrumental in driving innovative formulation strategies. In the industry, she has successfully established a formulation and test development lab, optimized drug delivery systems, and collaborated with engineers, scientists, professors, and regulatory experts to develop a novel inhaler device.

🏆 Bridging Academia & Industry

Her career is defined by her ability to translate research insights into practical applications, fostering innovation in formulation science. By integrating knowledge from both academic research and industrial applications, she continues to drive groundbreaking advancements in drug delivery systems, medical devices, and biomaterial coatings.

Notable Publications📝

📝Layer by Layer Coating for Bio-functionalization of Additively Manufactured Meta-Biomaterials

Authors: S Amin Yavari, M Croes, B Akhavan, F Jahanmard, CC Eigenhuis, Sasan Dadbakhsh, HC Vogely, MM Bilek, AC Fluit, CHE Boel, BCH Van Der Wal, T Vermonden, H Weinans, AA Zadpoor

Journal: Additive Manufacturing

Year: 2020

📝Bactericidal Coating to Prevent Early and Delayed Implant-Related Infections

Authors: F Jahanmard, M Croes, M Castilho, A Majed, MJ Steenbergen, K Lietaert, HC Vogely, BCH Van Der Wal, DAC Stapels, J Malda, T Vermonden, S Amin Yavari

Journal: Journal of Controlled Release

Year: 2020

📝Effect of Nanoporous Fibers on Growth and Proliferation of Cells on Electrospun Poly (ϵ-Caprolactone) Scaffolds

Authors: Fatemeh Jahanmard Hossein Abadi, Mohammad Amani Tehran, Fatemeh Zamani, Marziyeh Nematollahi, Laleh Ghasemi Mobarakeh, Mohammad Hossein Nasr-Esfahani

Journal: International Journal of Polymeric Materials and Polymeric Biomaterials

Year: 2014

📝Controlled Temperature-Mediated Curcumin Release from Magneto-Thermal Nanocarriers to Kill Bone Tumors

Authors: A Khodaei, F Jahanmard, HR Madaah Hosseini, R Bagheri, A Dabbagh, H Weinans, S Amin Yavari

Journal: Bioactive Materials

Year: 2022

📝A Multifunctional Silk Coating on Additively Manufactured Porous Titanium to Prevent Implant-Associated Infection and Stimulate Bone Regeneration

Authors: Z Gorgin Karaji, F Jahanmard, AH Mirzaei, B Van der Wal, S Amin Yavari

Journal: Biomedical Materials

Year: 2020

 

Dr. sherif Hosny, Medicinal Chemistry, Best Researcher Award

Posted on by sciencefather

Dr. sherif Hosny, Medicinal Chemistry, Best Researcher Award

Doctorate at EHA, Egypt

Professional Profiles

Google Scholar 

Scopus

🎓 Educational Background

He attended German School Dokki, Cairo from 1984 to 1994, achieving his Abitur with a grade of 1.9. From 1994 to 1998, he studied at the Faculty of Pharmacy, Cairo University, where he earned a Bachelor’s Degree in Pharmaceutical Science, graduating with Excellent with honors.In March 2000, he began his postgraduate studies at the Faculty of Pharmacy, Cairo University, registering for a Master’s degree in pharmaceutical science, specializing in the pharmacognosy department. His research focused on the topic: “A Contribution to the Study of Certain Hepatoprotective Plants Belonging to Family Apiaceae and Asteraceae.” Between 2005 and 2007, he completed a Diploma in Health Care Administration at the American University in Cairo.

In April 2008, he participated in a Fellowship at St. Jude Children’s Hospital. In September 2010, he registered for an MSc in Clinical Pharmacy at the Faculty of Pharmacy, Cairo University. He furthered his education by attending the Basis and Intermediate Master Class in Oncology Pharmacy in Vienna, Austria in October 2012, followed by the Advanced Master Class in Oncology Pharmacy in Dresden, Germany in October 2013.He obtained a Master’s Degree in Pharmaceutical Science, specializing in Clinical Pharmacy from the Faculty of Pharmacy, Cairo University in September 2015. His thesis was titled: “The Use of Valproic Acid in Pediatric Oncology Setting.” In 2016, he became a Certified Professional Trainer through the American University in Cairo. Finally, in September 2018, he became a PhD Candidate in Pharmaceutical Science, specializing in Clinical Pharmacy. His research topic is: “Evaluation of Antimicrobial Stewardship Program in Pediatric Oncology.”

🏆 Awards

He has received several prestigious awards, including the German President Award for Students, an Award from the Egyptian Hospital Pharmacist Association, and the First Lady Award for Excellence in 2010. He was recognized at the 1st Student Development Conference at Sinai University in 2010 and received the Egyptian Pharmacy Syndicate Award in the same year. Most recently, he earned the Best Pharmacist Award in 2018 from the Egyptian Pharmacy Syndicate CME Committee.

💼 Work Experience

From May 1998 to September 2002, he worked as a Clinical Pharmacist at the National Cancer Institute, Cairo University. His key responsibilities included the I.V. admixture of antibiotics and cytotoxic agents, leading the Clinical Pharmacy Development Program, and serving as the Senior Clinical Pharmacist and Night Shift Manager. His achievements include establishing Policies, Procedures, and Guidelines for the Oncology Clinical Pharmacy and overseeing operations as Senior Pharmacist.From 1999 to 2006, he served as a Senior Clinical Pharmacy Consultant at the Domiatta Cancer Institute, Egyptian Ministry of Health, where he managed the Clinical Pharmacy Development Program and established a protocol book for oncology clinical practices. He directed Annual Strategic Planning for clinical pharmacy services.

He also worked at the Tanta Cancer Institute and Menia Cancer Institute as a Senior Clinical Pharmacy Consultant from 1999 to 2000, leading the Clinical Pharmacy Development Program and training nursing staff in oncology pharmacy practices. His achievements included developing Oncology Clinical Pharmacy Guidelines and designing an Oncology Nurse Training Program.From 2001 to 2007, he continued as a Senior Clinical Pharmacy Consultant at the Sohag Cancer Institute, where he led the Clinical Pharmacy Development Program and developed a protocol book, directing Annual Strategic Planning and establishing policies for oncology pharmacy.

From 2008 to 2009, he worked at Frensh Qasr El Eini, Cairo University, where he managed the Clinical Pharmacy Development Program and created a protocol book, implementing clinical pharmacy policies and planning procedures.Finally, from April 1999 to 2006, he was a Teaching Assistant in the Pharmacognosy Department at the Faculty of Pharmacy, Cairo University (Beni Suef). His responsibilities included preparing lab equipment, delivering lectures, and supervising students. His achievements enhanced Pharmacognosy teaching methods and improved student engagement.

publications Top Noted📄

SIOPE and ESOP recommendations for extemporaneous compounding of oral liquid medicine formulations in pediatric oncology

Authors: Otsokolhich, M., Annereau, M., Bauters, T., Vassal, G., Buraja, S.

Journal: EJC Paediatric Oncology

Year: 2024

Correlation of Genetic Polymorphism of CYP3A5 to Cyclophosphamide Efficacy and Toxicity in Rhabdomyosarcoma Pediatric Egyptian Cancer Patients

Authors: ElShereef, C.E., Zaki, H.F., Badary, O.A., El Naga, S.A., Saber, M.M.

Journal: Asian Pacific Journal of Cancer Prevention

Year: 2024

Optimizing vancomycin therapeutic drug monitoring compliance in pediatric oncology: towards personalized medication management

Authors: Mohamed, R.G., Saber, R., Hussein, M.A., Shalaby, L., Nagy, M.

Journal: Personalized Medicine

Year: 2024

Efficacy and Toxicity of Vincristine and CYP3A5 Genetic Polymorphism in Rhabdomyosarcoma Pediatric Egyptian Patients

Authors: Shalaby, N., Zaki, H.F., Badary, O.A., Abouelnaga, S., Saber, M.M.

Journal: Asian Pacific Journal of Cancer Prevention

Year: 2024

Current status of African pediatric oncology education efforts aligned with the Global Initiative for Childhood Cancer

Authors: van Heerden, J., Lisa Christine, I., Downing, J., Balagadde-Kambugu, J., Geel, J.

Journal: Pediatric Hematology and Oncology

Year: 2023

 

Dr. Mohammad Nazrul Islam Bhuiyan, Medicinal Chemistry, Outstanding Scientist Award

Posted on by sciencefather

Dr. Mohammad Nazrul Islam Bhuiyan, Medicinal Chemistry, Outstanding Scientist Award

Doctorate at BCSIR, Bangladesh

Professional Profiles

Google Scholar

Scopus

Orcid

🎓 Educational Background

Dr. Mohammad Nazrul Islam Bhuiyan has an extensive academic background with qualifications from renowned institutions around the world. He began his education in Bangladesh, where he completed his Secondary School Certificate (S.S.C) in 1994 from Rampur High School and Higher Secondary Certificate (H.S.C) from University Lab. College, Dhaka in 1996. He then pursued a B.Sc. (Honors) in Botany from the University of Dhaka (2000) followed by an M.S in Botany from the same institution in 2001.

Dr. Bhuiyan expanded his academic prowess by earning a second M.S. in Microbiology from Hokkaido University, Japan in 2012, specializing in Sustainability Science through several advanced diplomas. Notably, he earned his Ph.D. in Microbiology from Hokkaido University in 2015, further cementing his expertise in the field.

👨‍🔬 Professional Experience

Dr. Bhuiyan currently holds the position of Principal Scientific Officer (PSO) at the Industrial Microbiology Laboratory of the Institute of Food Science and Technology (IFST), BCSIR, Dhaka, Bangladesh. As a leading figure in his department, Dr. Bhuiyan has contributed significantly to research in microbiology and sustainability sciences. His work has had a meaningful impact on the microbiological sciences in Bangladesh and beyond.

🏅 Special Achievements and Awards

Throughout his career, Dr. Bhuiyan has earned numerous prestigious accolades. He was recognized as the Best Young Scientist by the American Chemical Society in 2015 and received the Bill and Melinda Gates Foundation Travel Award in 2016, highlighting his active participation in global microbiology research. Additionally, he was honored as an Infectious Disease Fellow by the American Microbiology Society in 2017. He has also been awarded the MEXT Scholarship by the Japanese Government in 2010 and the RTFDCS Fellowship by the Indian Government in 2009.

🌿 International Exposure and Scientific Diplomacy

Dr. Bhuiyan’s international experiences include being a Visiting Scientist under the Indian Government Fellowship at the Forest Research Institute in Dehra Dun, India, and participating as a Scientific Diplomat at the World Student Environmental Summit in Switzerland in 2011. These roles underscore his contributions to international collaborations and scientific exchanges.

🧬 Conferences and Scientific Engagements

Dr. Bhuiyan has actively participated in numerous international conferences, where he has represented Bangladesh on a global stage. His notable conference participations include:

  • ASM Microbe Conference (2016, 2017) in the USA
  • International Conference on Food Security and Food Safety (2016) in Bangladesh
  • International Chemical Congress of Pacific Basin Societies (Pacifichem) (2015) in Hawaii, USA
  • International Union of Microbiology Society (IUMS) Congress (2014) in Montreal, Canada
    These conferences have allowed Dr. Bhuiyan to exchange knowledge and collaborate with world-renowned experts in microbiology and related fields.

🧑‍🔬 Memberships in Scientific Societies

Dr. Bhuiyan is a member of several prominent scientific organizations, reflecting his active involvement in the scientific community. These include:

  • American Society for Microbiology
  • The Japan Wood Research Society
  • The Chemical Society of Japan
  • The Canadian Society of Microbiologists
  • The Australian Society for Microbiology
  • American Chemical Society
  • Bangladesh Chemical Society

Publications Top Noted📖

Molecular characterization, antibiotic resistant pattern and biofilm forming potentiality of bacterial community associated with Ompok pabda fish farming in southwestern Bangladesh

Authors: Afrina Haque, Abhijit Chowdhury, Mohammad Nazrul Islam Bhuiyan, Banasree Bhowmik, Sadia Afrin, Rajib Sarkar, Md Mansurul Haque

Journal: Microbial Pathogenesis

Year: 2024-09

Enhancing prebiotic, antioxidant, and nutritional qualities of noodles: A collaborative strategy with foxtail millet and green banana flour

Authors: Tasnim Farzana, Syed Amir Ashraf, Md. Jaynal Abedin, Abu Tareq Mohammad Abdullah, Akter Hossain Reaz, Mohammad Nazrul Islam Bhuiyan, Sadia Afrin, Mohammed Abdus Satter

Journal: PLOS ONE

Year: 2024-08-19

Exploration and characterization of a newly isolated bacterium, Enterobacter quasihormaechei strain BDIFST24001, capable of producing rhamnolipid biosurfactant for oil remediation

Authors: Afsana Habib Jui, Mohammad Nazrul Islam Bhuiyan, Banasree Bhowmik, Nazia Khatun, Abhijit Chowdhury, Riyadh Hossen Bhuiyan, Md. Alamgir Kabir, Md. Mamunur Rashid, Md. Habibur Rahman Bhuiyan, Sadia Afrin

Journal: Access Microbiology

Year: 2024-08-01

Exploration and characterization of a newly isolated bacterium, Enterobacter quasihormaechei strain BDIFST24001, capable of producing rhamnolipids biosurfactant for oil remediation

Authors: Afsana Habib Jui, Mohammad Nazrul Islam Bhuiyan, Banasree Bhowmik, Nazia Khatun, Abhijit Chowdhury, Riyadh Hossen Bhuiyan, Md. Alamgir Kabir, Md. Mamunur Rashid, Md. Habibur Rahman Bhuiyan, Sadia Afrin

Journal: Access Microbiology (Preprint)

Year: 2024-07-15

Exploration and characterization of a newly isolated bacterium, Enterobacter quasihormaechei strain BDIFST24001, capable of producing rhamnolipids biosurfactant for oil remediation

Authors: Afsana Habib Jui, Mohammad Nazrul Islam Bhuiyan, Banasree Bhowmik, Nazia Khatun, Abhijit Chowdhury, Riyadh Hossen Bhuiyan, Md. Alamgir Kabir, Md. Mamunur Rashid, Md. Habibur Rahman Bhuiyan, Sadia Afrin

Journal: Access Microbiology (Preprint)

Year: 2024-07-09

 

Mrs. Kathrin Schön, Pharmaceutical Chemistry, Best Researcher Award

Posted on by sciencefather

Mrs. Kathrin Schön, Pharmaceutical Chemistry, Best Researcher Award

Mrs. Kathrin Schön, CSL Behring Innovation GmbH, Marburg, Germany, Germany

Profile

Orcid

Summary 📋

Dr. Kathrin Schön is a dedicated medical professional specializing in human genetics. With extensive experience in genetic counseling, molecular genetics, and cytogenetic analysis, she combines her clinical expertise with a robust research background in pharmacology and toxicology.

Education 🎓

Medicine (10/2013 – 11/2021), Philipps University Marburg
Licence to practise medicine on December 08, 2021

MD Thesis (03/2018 – ongoing), CSL Behring Innovation GmbH, Marburg
“Characterization of rFIX fusion proteins enabling subcutaneous administration”

Professional Experience 🏥

Physician in Human Genetics (since 07/2023), IMD Humangenetik Wiesbaden

Genetic counseling, examination, molecular genetic analysis, and cytogenetic laboratory work

Medical Affairs Trainee (10/2022 – 04/2023), Dr. Reiner Rittinghausen GmbH

Account management and sales

Physician (01/2022 – 08/2022), Local Health Department′s Coronavirus Faculty, Marburg

Consultant (01/2020 – ongoing), Clinical Development, CSL Behring Innovation GmbH

MD Thesis Doctoral Student (03/2018 – ongoing), CSL Behring Innovation GmbH, Marburg

Research Interests 🔬

Human Genetics: Genetic counseling and molecular genetic analysis

Pharmacology & Toxicology: Characterization of recombinant Factor IX fusion proteins

Hematology and Oncology: Clinical studies and patient care in hematology and oncology

Publications📚

Characterization of recombinant Factor IX fusion proteins enabling subcutaneous administration

Authors: Kathrin Schön, Sabine Pestel, Julia Riedesel, Waltraud Seyfert-Brandt, Philipp Claar, Eva Herzog, Alireza Rezvani-Sharif, Padmapriya Ponnuswamy, Marc W. Nolte

Journal: Journal of Thrombosis and Haemostasis

Year: 2024

Patient‐physician interactions in hereditary angioedema—Key learnings from the coronavirus disease 2019 pandemic

Authors: Maurer M, Buttgereit T, Magerl M, Schön K, Balla Z, Farkas H

Journal: Clinical and Translational Allergy

Year: 2023

Conference Poster: Characterization of rFIX fusion proteins enabling subcutaneous administration

Authors: Kathrin Schön, J. Riedesel, W. Seyfert-Brandt, S. Pestel, M. Mischnik, W. Azar, W. Hardy, M.W. Nolte, P. Claar

Journal: 65th Annual Meeting of the Society of Thrombosis and Hemostasis Research

Year: 2021